| - GRCh37:
- Chr3:39431001
- GRCh38:
- Chr3:39389510
| SLC25A38 | K29E | Sideroblastic anemia 2 | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435865
- GRCh38:
- Chr3:39394374
| SLC25A38 | | Sideroblastic anemia 2, not provided | Benign (Jul 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433147
- GRCh38:
- Chr3:39391656
| SLC25A38 | | Sideroblastic anemia 2, not provided | Benign (Jul 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39435899
- GRCh38:
- Chr3:39394408
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433449
- GRCh38:
- Chr3:39391958
| SLC25A38 | D188H | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433063-39433064
- GRCh38:
- Chr3:39391572-39391573
| SLC25A38 | A137fs | Sideroblastic anemia 2, not provided | Pathogenic (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433474
- GRCh38:
- Chr3:39391983
| SLC25A38 | L196P | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433095
- GRCh38:
- Chr3:39391604
| SLC25A38 | I147N | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431082
- GRCh38:
- Chr3:39389591
| SLC25A38 | Q56K | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39437975
- GRCh38:
- Chr3:39396484
| SLC25A38 | Y293* | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431999
- GRCh38:
- Chr3:39390508
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431949-39431958
- GRCh38:
- Chr3:39390458-39390467
| SLC25A38 | K76fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39437954
- GRCh38:
- Chr3:39396463
| SLC25A38 | A287fs, S231fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432974-39432980
- GRCh38:
- Chr3:39391483-39391489
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433084-39433086
- GRCh38:
- Chr3:39391593-39391595
| SLC25A38 | I144fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431982
- GRCh38:
- Chr3:39390491
| SLC25A38 | W87* | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435964
- GRCh38:
- Chr3:39394473
| SLC25A38 | L230P | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433356
- GRCh38:
- Chr3:39391865
| SLC25A38 | G157R | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432936
- GRCh38:
- Chr3:39391445
| SLC25A38 | I94N | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435958
- GRCh38:
- Chr3:39394467
| SLC25A38 | G228V | not provided, Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Mar 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39437928
- GRCh38:
- Chr3:39396437
| SLC25A38 | P222R, R278G | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433456
- GRCh38:
- Chr3:39391965
| SLC25A38 | P190R | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433044
- GRCh38:
- Chr3:39391553
| SLC25A38 | G130E | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432991-39433001
- GRCh38:
- Chr3:39391500-39391510
| SLC25A38 | K112fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39437928
- GRCh38:
- Chr3:39396437
| SLC25A38 | P222L, R278* | Sideroblastic anemia 2 | Pathogenic (Mar 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39431091
- GRCh38:
- Chr3:39389600
| SLC25A38 | Q59* | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433056
- GRCh38:
- Chr3:39391565
| SLC25A38 | R134H | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435947
- GRCh38:
- Chr3:39394456
| SLC25A38 | I225fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433447
- GRCh38:
- Chr3:39391956
| SLC25A38 | R187Q | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433366-39433367
- GRCh38:
- Chr3:39391875-39391876
| SLC25A38 | I161fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438009
- GRCh38:
- Chr3:39396518
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432960
- GRCh38:
- Chr3:39391469
| SLC25A38 | G102E | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39437903-39437904
- GRCh38:
- Chr3:39396412-39396413
| SLC25A38 | F271fs, L215fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39436072
- GRCh38:
- Chr3:39394581
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435940-39435953
- GRCh38:
- Chr3:39394449-39394462
| SLC25A38 | C223fs | Sideroblastic anemia 2, not provided | Conflicting interpretations of pathogenicity (Sep 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39433362
- GRCh38:
- Chr3:39391871
| SLC25A38 | E159fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433343
- GRCh38:
- Chr3:39391852
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433043
- GRCh38:
- Chr3:39391552
| SLC25A38 | G130R | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433013
- GRCh38:
- Chr3:39391522
| SLC25A38 | P121fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432930
- GRCh38:
- Chr3:39391439
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431999
- GRCh38:
- Chr3:39390508
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431923-39431930
- GRCh38:
- Chr3:39390432-39390439
| SLC25A38 | M70fs | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438729
- GRCh38:
- Chr3:39397238
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438560
- GRCh38:
- Chr3:39397069
| SLC25A38 | | Sideroblastic anemia 2 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438559
- GRCh38:
- Chr3:39397068
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438558
- GRCh38:
- Chr3:39397067
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431921
- GRCh38:
- Chr3:39390430
| SLC25A38 | R67C | not provided, Inborn genetic diseases, Sideroblastic anemia 2
| Uncertain significance (Jul 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39425201
- GRCh38:
- Chr3:39383710
| LOC129936510, SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438406
- GRCh38:
- Chr3:39396915
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438392
- GRCh38:
- Chr3:39396901
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438316
- GRCh38:
- Chr3:39396825
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39425177
- GRCh38:
- Chr3:39383686
| SLC25A38, LOC129936510 | | Sideroblastic anemia 2 | Uncertain significance (Mar 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438223
- GRCh38:
- Chr3:39396732
| SLC25A38 | | not provided, Sideroblastic anemia 2 | Benign (Jul 9, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39436055
- GRCh38:
- Chr3:39394564
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435896
- GRCh38:
- Chr3:39394405
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433512
- GRCh38:
- Chr3:39392021
| SLC25A38 | D209N, G209R | Sideroblastic anemia 2 | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433415
- GRCh38:
- Chr3:39391924
| SLC25A38 | | Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39424943
- GRCh38:
- Chr3:39383452
| SLC25A38 | | not provided, Sideroblastic anemia 2 | Likely benign (Jul 9, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433121
- GRCh38:
- Chr3:39391630
| SLC25A38 | | not provided, Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Jul 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39432957
- GRCh38:
- Chr3:39391466
| SLC25A38 | V101A | Sideroblastic anemia 2, not provided | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39432935
- GRCh38:
- Chr3:39391444
| SLC25A38 | I94V | Sideroblastic anemia 2 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39435946-39435947
- GRCh38:
- Chr3:39394455-39394456
| SLC25A38 | I225fs | Sideroblastic anemia 2 | Likely pathogenic (Jun 20, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39425226
- GRCh38:
- Chr3:39383735
| LOC129936510, SLC25A38 | N4S | not provided, Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Jun 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39433512
- GRCh38:
- Chr3:39392021
| SLC25A38 | D209H, G209R | Sideroblastic anemia 2 | Pathogenic/Likely pathogenic (Jun 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433055
- GRCh38:
- Chr3:39391564
| SLC25A38 | R134C | Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Jun 1, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39430984
- GRCh38:
- Chr3:39389493
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433373
- GRCh38:
- Chr3:39391882
| SLC25A38 | | Sideroblastic anemia 2, not specified, not provided
| Conflicting interpretations of pathogenicity (Oct 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39431918
- GRCh38:
- Chr3:39390427
| SLC25A38 | R66G | not provided, Sideroblastic anemia 2 | Benign/Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433412
- GRCh38:
- Chr3:39391921
| SLC25A38 | | Sideroblastic anemia 2, not provided | Conflicting interpretations of pathogenicity (May 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39438599
- GRCh38:
- Chr3:39397108
| SLC25A38 | | not provided, Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical)
| Benign/Likely benign (May 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39438501
- GRCh38:
- Chr3:39397010
| SLC25A38 | | X-linked sideroblastic anemia 1, Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39438483
- GRCh38:
- Chr3:39396992
| SLC25A38 | | X-linked sideroblastic anemia 1, not provided, Sideroblastic anemia 2
| Benign/Likely benign (May 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39438442
- GRCh38:
- Chr3:39396951
| SLC25A38 | | not provided, Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical)
| Conflicting interpretations of pathogenicity (May 24, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39438415
- GRCh38:
- Chr3:39396924
| SLC25A38 | | Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical) | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438381
- GRCh38:
- Chr3:39396890
| SLC25A38 | | Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical) | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39438321
- GRCh38:
- Chr3:39396830
| SLC25A38 | | not provided, Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical)
| Benign (Jun 14, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39438315
- GRCh38:
- Chr3:39396824
| SLC25A38 | | Sideroblastic anemia 2, X-linked sideroblastic anemia 1 | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39435927
- GRCh38:
- Chr3:39394436
| SLC25A38 | I218F | not provided, Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical)
| Uncertain significance (Jun 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39433457
- GRCh38:
- Chr3:39391966
| SLC25A38 | | Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical) | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433349
- GRCh38:
- Chr3:39391858
| SLC25A38 | | not provided, Sideroblastic anemia 2, X-linked sideroblastic anemia 1
| Conflicting interpretations of pathogenicity (Oct 4, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39433101
- GRCh38:
- Chr3:39391610
| SLC25A38 | T149M | X-linked sideroblastic anemia 1, Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433037
- GRCh38:
- Chr3:39391546
| SLC25A38 | M128V | Sideroblastic anemia 2, not specified, not provided, X-linked sideroblastic anemia 1 | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39432943
- GRCh38:
- Chr3:39391452
| SLC25A38 | | not provided, Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical)
| Uncertain significance (Oct 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39431961
- GRCh38:
- Chr3:39390470
| SLC25A38 | T80R | Inborn genetic diseases, not specified, Sideroblastic anemia 2, not provided, X-linked sideroblastic anemia 1 | Conflicting interpretations of pathogenicity (Oct 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39431077
- GRCh38:
- Chr3:39389586
| SLC25A38 | R54H | not provided, Sideroblastic anemia 2, X-linked sideroblastic anemia 1
| Uncertain significance (Jul 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39425227
- GRCh38:
- Chr3:39383736
| LOC129936510, SLC25A38 | | not provided, Sideroblastic anemia 2, X-linked sideroblastic anemia 1
| Conflicting interpretations of pathogenicity (Nov 2, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39425147
- GRCh38:
- Chr3:39383656
| SLC25A38 | | Sideroblastic anemia 2, X-linked sideroblastic anemia 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39425055
- GRCh38:
- Chr3:39383564
| SLC25A38 | | Sideroblastic anemia 2, Refractory anemia with ringed sideroblasts (clinical) | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39425007
- GRCh38:
- Chr3:39383516
| SLC25A38 | | Sideroblastic anemia 2, not provided, Refractory anemia with ringed sideroblasts (clinical)
| Benign/Likely benign (Jun 28, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39424997
- GRCh38:
- Chr3:39383506
| SLC25A38 | | X-linked sideroblastic anemia 1, Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39424991
- GRCh38:
- Chr3:39383500
| SLC25A38 | | X-linked sideroblastic anemia 1, Sideroblastic anemia 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39424989
- GRCh38:
- Chr3:39383498
| SLC25A38 | | X-linked sideroblastic anemia 1, Sideroblastic anemia 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39424979
- GRCh38:
- Chr3:39383488
| SLC25A38 | | Sideroblastic anemia 2, X-linked sideroblastic anemia 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39424924
- GRCh38:
- Chr3:39383433
| SLC25A38 | | not provided, Sideroblastic anemia 2, X-linked sideroblastic anemia 1
| Conflicting interpretations of pathogenicity (Jul 7, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr3:39424913
- GRCh38:
- Chr3:39383422
| SLC25A38 | | X-linked sideroblastic anemia 1, Sideroblastic anemia 2, not provided
| Benign/Likely benign (Jun 28, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39424891
- GRCh38:
- Chr3:39383400
| SLC25A38 | | Sideroblastic anemia 2, X-linked sideroblastic anemia 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39431081
- GRCh38:
- Chr3:39389590
| SLC25A38 | | not specified, Refractory anemia with ringed sideroblasts (clinical), not provided, Sideroblastic anemia 2 | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:39436065
- GRCh38:
- Chr3:39394574
| SLC25A38 | K264* | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39432931
- GRCh38:
- Chr3:39391440
| SLC25A38 | | Sideroblastic anemia 2 | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:39433447
- GRCh38:
- Chr3:39391956
| SLC25A38 | R187P | not provided, Sideroblastic anemia 2 | Conflicting interpretations of pathogenicity (Aug 21, 2022) | criteria provided, conflicting interpretations |